Tag Archives: Yi Chen
Stealth Biotherapeutics Corp (MITO) Receives a Buy from H.C. Wainwright
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Stealth Biotherapeutics Corp (MITO – Research Report) today and set a price target of $30.00. The company’s shares closed last Monday at $6.79, close to its 52-week low of $4.97.
Analysts Offer Insights on Consumer Goods Companies: Veru Inc (NASDAQ: VERU), Plantronics (NYSE: PLT) and Resonant (NASDAQ: RESN)
There’s a lot to be optimistic about in the Consumer Goods sector as 3 analysts just weighed in on Veru Inc (VERU – Research Report), Plantronics (PLT – Research Report) and Resonant (RESN – Research Report) with bullish sentiments. Veru
H.C. Wainwright Reiterates Their Buy Rating on Interpace Diagnostics Group Inc (IDXG)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Interpace Diagnostics Group Inc (IDXG – Research Report) today and set a price target of $2.00. The company’s shares closed last Monday at $0.79, close to its 52-week low of
H.C. Wainwright Sticks to Their Buy Rating for Oragenics Inc (OGEN)
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Oragenics Inc (OGEN – Research Report), with a price target of $2.00. The company’s shares closed last Monday at $0.56, close to its 52-week low
Ocular Therapeutix (OCUL) Gets a Buy Rating from H.C. Wainwright
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Ocular Therapeutix (OCUL – Research Report) today and set a price target of $9.00. The company’s shares closed last Monday at $3.82. According to TipRanks.com, Chen ‘s ranking currently consits
H.C. Wainwright Reiterates Their Buy Rating on EyePoint Pharmaceuticals Inc (EYPT)
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on EyePoint Pharmaceuticals Inc (EYPT – Research Report), with a price target of $4.50. The company’s shares closed last Monday at $1.92. According to TipRanks.com, Chen
